Incidence of Pain After Craniotomy in Children
Launched by SAN GERARDO HOSPITAL · Jun 10, 2010
Trial Information
Current as of June 10, 2025
Completed
Keywords
ClinConnect Summary
Research in the adult population has evaluated incidence and severity of post-neurosurgical pain, and effectiveness of different post-neurosurgical analgesic regimens. Several small studies report the prevalence of some period of moderate to severe pain in the first 24 postoperative hours to be from 41 to 84 % of patients. In a prospective single academic medical institution study, adult patients treated with only acetaminophen and modest amounts of opioids on an as needed basis reported moderate to severe pain for the first 2 days after surgery. These findings have supported a growing cons...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Male and Female children from 1 month to 10 years Of age
- • American Society of Anaesthesiologists Classification (ASA) I-III
- • Scheduled for supratentorial or infratentorial craniotomy
- • Admission to an Intensive Care Unit, Neurosurgery ward or paediatric ward of one of the hospitals included
- • Children whose parents (or legal tutors) have given their informed written consent
- Exclusion Criteria:
- • Emergency surgery for multiple trauma.
- • Children requiring muscular relaxants during the postoperative period
- • Children whose parents (or legal tutors) denied their own consensus
About San Gerardo Hospital
San Gerardo Hospital is a leading healthcare institution dedicated to advancing medical research and improving patient care through innovative clinical trials. With a commitment to excellence, the hospital collaborates with multidisciplinary teams of experienced clinicians and researchers to conduct trials that address critical health challenges. San Gerardo Hospital prioritizes the safety and well-being of its participants while striving to enhance therapeutic options and contribute to the scientific community. Through its rigorous adherence to ethical standards and regulatory compliance, the hospital fosters an environment of trust and collaboration, ensuring that groundbreaking discoveries translate into tangible benefits for patients and the broader healthcare landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Torino, , Italy
Bergamo, , Italy
Padova, , Italy
Rome, , Italy
Catania, , Italy
Firenze, , Italy
Genova, , Italy
Milano, , Italy
Patients applied
Trial Officials
Pablo M. Ingelmo, MD
Principal Investigator
San Gerardo Hospital
Marta Somaini, MD
Study Chair
San Gerardo Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials